PlainPharmaWatch

CMS Open Payments · Program Year 2024

Zyla Life Sciences, Inc.

Zyla Life Sciences, Inc. reported $45,000.00 in payments to 0 physicians and teaching hospitals across 1 transactions.

See the rankings → How this is sourced
$45.0K
Total payments
1
Transactions
0
Recipients
#1379
of 1,925 companies

Zyla Life Sciences, Inc. reported $45,000.00 in payments to 0 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1379 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $0.00 per recipient across 0 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Zyla Life Sciences, Inc. posts below-median payment volume among 1,925 companies reporting payments in CMS Open Payments PY2024.

#1379
of 1,925 companies
0.0%
of all US industry payments
0
payment categories

How Zyla Life Sciences, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Zyla Life Sciences, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$45,000 28th percentile higher than 28% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). This entry sits in this band. $78,003–$242,294: 295 reporting companies (15%). Above this entry. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Zyla Life Sciences, Inc.

Zyla Life Sciences, Inc. ranks #1379 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $45,000.00 across 1 transactions to 0 physicians and teaching hospitals - $45.0K per transaction and $0.00 per recipient on average.

The 0-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). Payments are distributed across multiple categories without a dominant single type.

Payment Size Analysis

Average transaction size: $45.0K. Average per recipient: $0.00.

Total Amount

$45,000.00

Avg per Transaction

$45.0K

Avg per Recipient

$0.00

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Zyla Life Sciences, Inc. Share

0.0%

#1379 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Zyla Life Sciences, Inc.

AccuTec Blades Inc

$45.1K 9 recipients

NeuroOne Medical Technologies Corporation

$44.7K 40 recipients

Hollister Incorporated

$45.3K 370 recipients

Mercator MedSystems, Inc.

$45.4K 12 recipients

CMS Imaging, Inc.

$44.5K 418 recipients

OptumHealth Care Solutions, LLC

$44.5K 2,039 recipients

Frequently Asked Questions

How much did Zyla Life Sciences, Inc. pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $45,000.00 from Zyla Life Sciences, Inc. to physicians and hospitals across 1 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from Zyla Life Sciences, Inc.? ▾
Zyla Life Sciences, Inc. made payments to 0 physicians and teaching hospitals in 2024. The average payment per recipient was $0.00.
What types of payments did Zyla Life Sciences, Inc. make? ▾
0 categories of general payment make up Zyla Life Sciences, Inc.'s reported activity, including consulting, meals, travel, and similar types.
How does Zyla Life Sciences, Inc. rank among pharmaceutical companies? ▾
By total payment amount, Zyla Life Sciences, Inc. sits at #1379 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Zyla Life Sciences, Inc.? ▾
Zyla Life Sciences, Inc.'s 1 transactions to 0 recipients in 2024 averaged $45.0K per transaction.
Where does the payment data for Zyla Life Sciences, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Zyla Life Sciences, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.